vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.

Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -2.3%, a 9.7% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 9.1%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-7.8M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 8.3%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”

HROW vs PRPL — Head-to-Head

Bigger by revenue
PRPL
PRPL
1.6× larger
PRPL
$140.7M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+24.2% gap
HROW
33.3%
9.1%
PRPL
Higher net margin
HROW
HROW
9.7% more per $
HROW
7.4%
-2.3%
PRPL
More free cash flow
HROW
HROW
$15.9M more FCF
HROW
$8.1M
$-7.8M
PRPL
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
8.3%
PRPL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
PRPL
PRPL
Revenue
$89.1M
$140.7M
Net Profit
$6.6M
$-3.2M
Gross Margin
79.3%
41.9%
Operating Margin
17.5%
-1.6%
Net Margin
7.4%
-2.3%
Revenue YoY
33.3%
9.1%
Net Profit YoY
-2.2%
62.1%
EPS (diluted)
$0.20
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
PRPL
PRPL
Q4 25
$89.1M
$140.7M
Q3 25
$71.6M
$118.8M
Q2 25
$63.7M
$105.1M
Q1 25
$47.8M
$104.2M
Q4 24
$66.8M
$129.0M
Q3 24
$49.3M
$118.6M
Q2 24
$48.9M
$120.3M
Q1 24
$34.6M
$120.0M
Net Profit
HROW
HROW
PRPL
PRPL
Q4 25
$6.6M
$-3.2M
Q3 25
$1.0M
$-11.7M
Q2 25
$5.0M
$-17.3M
Q1 25
$-17.8M
$-19.1M
Q4 24
$6.8M
$-8.5M
Q3 24
$-4.2M
$-39.2M
Q2 24
$-6.5M
$27.0K
Q1 24
$-13.6M
$-50.2M
Gross Margin
HROW
HROW
PRPL
PRPL
Q4 25
79.3%
41.9%
Q3 25
75.3%
42.8%
Q2 25
74.5%
35.9%
Q1 25
67.5%
39.4%
Q4 24
78.8%
42.9%
Q3 24
75.6%
29.7%
Q2 24
74.4%
40.7%
Q1 24
69.5%
34.8%
Operating Margin
HROW
HROW
PRPL
PRPL
Q4 25
17.5%
-1.6%
Q3 25
20.6%
-10.2%
Q2 25
17.9%
-13.5%
Q1 25
-23.5%
-13.9%
Q4 24
19.3%
-6.0%
Q3 24
2.7%
-39.5%
Q2 24
3.1%
-12.1%
Q1 24
-20.0%
-19.3%
Net Margin
HROW
HROW
PRPL
PRPL
Q4 25
7.4%
-2.3%
Q3 25
1.4%
-9.9%
Q2 25
7.8%
-16.5%
Q1 25
-37.2%
-18.4%
Q4 24
10.1%
-6.6%
Q3 24
-8.6%
-33.1%
Q2 24
-13.2%
0.0%
Q1 24
-39.2%
-41.8%
EPS (diluted)
HROW
HROW
PRPL
PRPL
Q4 25
$0.20
$0.03
Q3 25
$0.03
$0.11
Q2 25
$0.13
$0.16
Q1 25
$-0.50
$0.18
Q4 24
$0.19
$0.08
Q3 24
$-0.12
$0.36
Q2 24
$-0.18
$0.00
Q1 24
$-0.38
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
PRPL
PRPL
Cash + ST InvestmentsLiquidity on hand
$72.9M
$24.3M
Total DebtLower is stronger
$250.0M
$126.7M
Stockholders' EquityBook value
$52.4M
$-29.7M
Total Assets
$399.5M
$296.3M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
PRPL
PRPL
Q4 25
$72.9M
$24.3M
Q3 25
$74.3M
$32.4M
Q2 25
$53.0M
$34.2M
Q1 25
$66.7M
$21.6M
Q4 24
$47.2M
$29.0M
Q3 24
$72.6M
$23.4M
Q2 24
$71.0M
$23.4M
Q1 24
$76.0M
$34.5M
Total Debt
HROW
HROW
PRPL
PRPL
Q4 25
$250.0M
$126.7M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
$70.7M
Q3 24
$230.7M
$50.8M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
PRPL
PRPL
Q4 25
$52.4M
$-29.7M
Q3 25
$47.0M
$-26.9M
Q2 25
$49.7M
$-15.6M
Q1 25
$56.5M
$1.3M
Q4 24
$69.7M
$20.2M
Q3 24
$58.0M
$28.0M
Q2 24
$58.5M
$66.4M
Q1 24
$60.6M
$65.5M
Total Assets
HROW
HROW
PRPL
PRPL
Q4 25
$399.5M
$296.3M
Q3 25
$363.1M
$302.1M
Q2 25
$345.0M
$303.8M
Q1 25
$364.2M
$293.8M
Q4 24
$389.0M
$307.8M
Q3 24
$351.5M
$309.3M
Q2 24
$306.6M
$362.1M
Q1 24
$295.5M
$382.1M
Debt / Equity
HROW
HROW
PRPL
PRPL
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
3.50×
Q3 24
3.98×
1.82×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
PRPL
PRPL
Operating Cash FlowLast quarter
$8.4M
$-5.8M
Free Cash FlowOCF − Capex
$8.1M
$-7.8M
FCF MarginFCF / Revenue
9.1%
-5.5%
Capex IntensityCapex / Revenue
0.4%
1.4%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
PRPL
PRPL
Q4 25
$8.4M
$-5.8M
Q3 25
$16.6M
$-968.0K
Q2 25
$-803.0K
$-4.0M
Q1 25
$19.7M
$-23.1M
Q4 24
$-17.8M
$6.8M
Q3 24
$3.0M
$1.1M
Q2 24
$-2.7M
$-8.9M
Q1 24
$-4.6M
$-16.8M
Free Cash Flow
HROW
HROW
PRPL
PRPL
Q4 25
$8.1M
$-7.8M
Q3 25
$16.4M
$-1.8M
Q2 25
$-969.0K
$-7.0M
Q1 25
$19.5M
$-25.3M
Q4 24
$-18.3M
$5.7M
Q3 24
$2.3M
$101.0K
Q2 24
$-3.1M
$-11.0M
Q1 24
$-4.7M
$-19.9M
FCF Margin
HROW
HROW
PRPL
PRPL
Q4 25
9.1%
-5.5%
Q3 25
22.9%
-1.5%
Q2 25
-1.5%
-6.6%
Q1 25
40.8%
-24.3%
Q4 24
-27.4%
4.4%
Q3 24
4.8%
0.1%
Q2 24
-6.3%
-9.2%
Q1 24
-13.6%
-16.5%
Capex Intensity
HROW
HROW
PRPL
PRPL
Q4 25
0.4%
1.4%
Q3 25
0.3%
0.7%
Q2 25
0.3%
2.8%
Q1 25
0.4%
2.2%
Q4 24
0.8%
0.8%
Q3 24
1.2%
0.9%
Q2 24
0.7%
1.7%
Q1 24
0.3%
2.5%
Cash Conversion
HROW
HROW
PRPL
PRPL
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
-330.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

PRPL
PRPL

Cost Of Revenues$81.7M58%
Other$59.0M42%

Related Comparisons